These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 28523522)

  • 21. Vaccinia virus serpin-1 deletion mutant exhibits a host range defect characterized by low levels of intermediate and late mRNAs.
    Shisler JL; Isaacs SN; Moss B
    Virology; 1999 Sep; 262(2):298-311. PubMed ID: 10502509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A conditional-lethal vaccinia virus mutant demonstrates that the I7L gene product is required for virion morphogenesis.
    Byrd CM; Hruby DE
    Virol J; 2005 Feb; 2():4. PubMed ID: 15701171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A vaccinia virus lacking A10L: viral core proteins accumulate on structures derived from the endoplasmic reticulum.
    Rodriguez D; Bárcena M; Möbius W; Schleich S; Esteban M; Geerts WJ; Koster AJ; Griffiths G; Locker JK
    Cell Microbiol; 2006 Mar; 8(3):427-37. PubMed ID: 16469055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. c-Jun integrates signals from both MEK/ERK and MKK/JNK pathways upon vaccinia virus infection.
    Leite FGG; Torres AA; De Oliveira LC; Da Cruz AFP; Soares-Martins JAP; Pereira ACTC; Trindade GS; Abrahão JS; Kroon EG; Ferreira PCP; Bonjardim CA
    Arch Virol; 2017 Oct; 162(10):2971-2981. PubMed ID: 28620810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccinia virus telomeres: interaction with the viral I1, I6, and K4 proteins.
    DeMasi J; Du S; Lennon D; Traktman P
    J Virol; 2001 Nov; 75(21):10090-105. PubMed ID: 11581377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunolocalization of vaccinia virus structural proteins during virion formation.
    Vanslyke JK; Hruby DE
    Virology; 1994 Feb; 198(2):624-35. PubMed ID: 8291244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts.
    Martin A; Escriou N; Chao SF; Girard M; Lemon SM; Wychowski C
    Virology; 1995 Oct; 213(1):213-22. PubMed ID: 7483265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the interactions among vaccinia virus transcription factors G2R, A18R, and H5R.
    Black EP; Moussatche N; Condit RC
    Virology; 1998 Jun; 245(2):313-22. PubMed ID: 9636370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visna/maedi virus Env protein expressed by a vaccinia virus recombinant induces cell-to-cell fusion in cells of different origins in the apparent absence of Env cleavage: role of glycosylation and of proteoglycans.
    Sánchez AB; Rodríguez D; Garzón A; Amorena B; Esteban M; Rodríguez JR
    Arch Virol; 2002 Dec; 147(12):2377-92. PubMed ID: 12491104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of vaccinia virus replication by N-(phosphonoacetyl)-L-aspartate: differential effects on viral gene expression result from a reduced pyrimidine nucleotide pool.
    Katsafanas GC; Grem JL; Blough HA; Moss B
    Virology; 1997 Sep; 236(1):177-87. PubMed ID: 9299630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccinia virus intermediate and late promoter elements are targeted by the TATA-binding protein.
    Knutson BA; Liu X; Oh J; Broyles SS
    J Virol; 2006 Jul; 80(14):6784-93. PubMed ID: 16809284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccinia virus core protein VP8 is required for virus infectivity, but not for core protein processing or for INV and EEV formation.
    Wilcock D; Smith GL
    Virology; 1994 Jul; 202(1):294-304. PubMed ID: 8009841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging of vaccinia virus entry into HeLa cells.
    Huang CY; Chang W
    Methods Mol Biol; 2012; 890():123-33. PubMed ID: 22688764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of IL-2 gene expression and nuclear factor-90 translocation in vaccinia virus-infected cells.
    Langland JO; Kao P; Jacobs BL
    J Interferon Cytokine Res; 2003 Sep; 23(9):489-500. PubMed ID: 14565858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex.
    Wagenaar TR; Moss B
    J Virol; 2007 Jun; 81(12):6286-93. PubMed ID: 17409143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteins released from vaccinia cores are probably not involved in protein synthesis inhibition in vitro.
    Dâmaso CR; Moussatché N
    Braz J Med Biol Res; 1992; 25(2):115-24. PubMed ID: 1339506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccinia virus protein A3 is required for the production of normal immature virions and for the encapsidation of the nucleocapsid protein L4.
    Jesus DM; Moussatche N; McFadden BB; Nielsen CP; D'Costa SM; Condit RC
    Virology; 2015 Jul; 481():1-12. PubMed ID: 25765002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation of ribosomal proteins in HeLa cells infected with vaccinia virus.
    Kaerlein M; Horak I
    Nature; 1976 Jan; 259(5539):150-1. PubMed ID: 1246353
    [No Abstract]   [Full Text] [Related]  

  • 39. Viral exploitation of the MEK/ERK pathway - A tale of vaccinia virus and other viruses.
    Bonjardim CA
    Virology; 2017 Jul; 507():267-275. PubMed ID: 28526201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of host proteins interacting with the lymphocytic choriomeningitis virus L protein.
    Khamina K; Lercher A; Caldera M; Schliehe C; Vilagos B; Sahin M; Kosack L; Bhattacharya A; Májek P; Stukalov A; Sacco R; James LC; Pinschewer DD; Bennett KL; Menche J; Bergthaler A
    PLoS Pathog; 2017 Dec; 13(12):e1006758. PubMed ID: 29261807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.